Stockholm 17:30
-0,47% Idag
+25,05% Sedan årsskifte
-0,01% OMXSPI

2019-03-04 07:05:00

Integrum AB: Integrum and Sahlgrenska sign new contract for OPRA™ Implant System

Mölndal, 04 March 2019

Integrum, a leading provider ofinnovative solutions for bone anchored prosthetics, has today announced it has signed a two-year contract with Sahlgrenska University Hospital in Gothenburg, Sweden, to supply the hospital with OPRA™ Implant System products.

The OPRA™Implant System will be an integral part of Sahlgrenska's relaunch of its osseointegration surgery services that will provide amputee patients with a new alternative to the traditionally used socket prosthesis. 

Rutger Barrdahl, CEO at Integrum, says, "We are really happy to be supplying our latest OPRA™Implant System products to Sahlgrenska. It's a fresh new start for our collaboration, and we're very much looking forward to working closely with the osseointegration team at Sahlgrenska to help individuals with amputations towards an improved quality of life."  

For more information about Integrum, please contact:
Rutger Barrdahl, CEO
Tel. +46 705 23 39 55 

Certified Adviser:

Erik Penser Bank AB

Tel. +46 8 463 8000 

About Integrum 

Integrum AB is a publicly traded company (INTEG B: Nasdaq First North exchange) based outside of Gothenburg, Sweden with a U.S. subsidiary in San Francisco, CA. Since 1990 osseointegration, the science behind the OPRA™ Implant System, has been helping individuals with amputations towards an improved quality of life. Thorough surgical experience gained over almost three decades from 500 surgeries in 13 countries has led to the development of Integrum's system for bone-anchored prosthetics - a beneficial alternative to the traditionally used socket prosthesis. Integrum's OPRA™ Implant System was approved by the U.S. Food and Drug Administration (FDA) in 2015 for use in the U.S. under a Humanitarian Use Device (HUD) designation which was reviewed through the Humanitarian Device Exemption (HDE) pathway. The OPRA™ Implant System is the only FDA approved technology for bone anchored prosthetics available in the U.S. More information on the company and its innovative solutions for amputees can be found at 

Attached html: HTML
Attached pdf: PDF